يعرض 1 - 10 نتائج من 238 نتيجة بحث عن '"Garcia-Alfonso, Pilar"', وقت الاستعلام: 0.92s تنقيح النتائج
  1. 1
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, García Alfonso P Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria (IiSGM), Universidad Complutense de Madrid, Madrid, Spain. Vera R Department of Oncology, University Hospital of Navarra, Instituto de Investigación Sanitaria de Navarra (IdISNA), Pamplona, Navarra, Spain. Aranda E Department of Medical Oncology, Hospital Universitario Reina Sofía, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Universidad de Córdoba, Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Córdoba, Spain. Élez E Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Rivera F Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Clinical and Translational Oncology;26(6); https://doi.org/10.1007/s12094-023-03369-1Test; García-Alfonso P, Vera R, Aranda E, Élez E, Rivera F. Delphi consensus for the third-line treatment of metastatic colorectal cancer. Clin Transl Oncol. 2024 Jun;26(6):1429–1437.; https://hdl.handle.net/11351/11536Test; 001171852900001

  2. 2
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Elez E Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Cubillo A Centro Integral, Oncológico Clara Campal, HM CIOCC, Madrid, Spain. Facultad HM Hospitales de Ciencias de La Salud UCJC, Madrid, Spain. Garcia Alfonso P Medical Oncology Service, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Universidad Complutense, Madrid, Spain. Middleton MR Department of Oncology, NIHR Biomedical Research Centre, University of Oxford, Oxford, UK. Chau I Gastrointestinal Unit, Royal Marsden Hospital, London & Surrey, UK. Alkuzweny B Formerly Pfzer, Inc, San Diego, CA, USA, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: BMC Cancer;24(1); https://doi.org/10.1186/s12885-024-12153-5Test; Elez E, Cubillo A, Garcia Alfonso P, Middleton MR, Chau I, Alkuzweny B, et al. Binimetinib in combination with nivolumab or nivolumab and ipilimumab in patients with previously treated microsatellite-stable metastatic colorectal cancer with RAS mutations in an open-label phase 1b/2 study. BMC Cancer. 2024 Apr 11;24(1):446.; https://hdl.handle.net/11351/11333Test; 001199970900001

  3. 3
    دورية أكاديمية
  4. 4
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Fernández Montes A Medical Oncology Department, Complexo Hospitalario Universitario, Ourense (CHUO), Ourense, Spain. Alonso V Medical Oncology Department, Hospital Universitario Miguel Servet, Saragossa, Spain. Aranda E Medical Oncology Department, Hospital Universitario Reina Sofía, Córdoba, Spain. Élez E Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. García Alfonso P Medical Oncology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain. Grávalos C Medical Oncology Department, Hospital Universitario 12 de Octubre, Madrid, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Clinical and Translational Oncology;25; https://doi.org/10.1007/s12094-023-03199-1Test; Fernández Montes A, Alonso V, Aranda E, Élez E, García Alfonso P, Grávalos C, et al. SEOM-GEMCAD-TTD clinical guidelines for the systemic treatment of metastatic colorectal cancer (2022). Clin Transl Oncol. 2023 Sep;25:2718–31.; https://hdl.handle.net/11351/10232Test; 000980817100001

  5. 5
    دورية أكاديمية
  6. 6
    دورية أكاديمية
  7. 7
    دورية أكاديمية

    المساهمون: Argilés, Guillem, Mulet, Nuria, Valladares-Ayerbes, Manuel, Viéitez, José M, Grávalos, Cristina, García-Alfonso, Pilar, Santos, Cristina, Tobeña, María, García-Paredes, Beatriz, Benavides, Manuel, Cano, María T, Loupakis, Fotio, Rodríguez-Garrote, Mercede, Rivera, Fernando, Goldberg, Richard M, Cremolini, Chiara, Bennouna, Jaafar, Ciardiello, Fortunato, Tabernero, Josep M, Aranda, Enrique, Tabernero, Josep

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/36335783; info:eu-repo/semantics/altIdentifier/wos/WOS:000893203300001; volume:177; firstpage:154; lastpage:163; numberofpages:10; journal:EUROPEAN JOURNAL OF CANCER; https://hdl.handle.net/11568/1169764Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85142882624; https://www.sciencedirect.com/science/article/pii/S0959804922007808Test

  8. 8
    دورية أكاديمية
  9. 9
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Vera R Navarra University Hospital, Spanish Society of Medical Oncology (SEOM), Pamplona, Spain. Ibarrola-de-Andrés C, Rodríguez-Gil Y 12 de Octubre University Hospital, Spanish Society of Pathology (SEAP), Madrid, Spain. Adeva J 12 de Octubre University Hospital, Spanish Society of Medical Oncology (SEOM), Madrid, Spain. Pérez-Rojas J La Fe University and Polytechnic Hospital, Spanish Society of Pathology (SEAP), Valencia, Spain. García-Alfonso P Gregorio Marañón University Hospital, Spanish Society of Medical Oncology (SEOM), Madrid, Spain. Macarulla T Vall d’Hebron Hospital Universitari, Barcelona, Spain. Spanish Society of Medical Oncology (SEOM), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Clinical and Translational Oncology;24; https://doi.org/10.1007/s12094-022-02873-0Test; Vera R, Ibarrola-de-Andrés C, Adeva J, Pérez-Rojas J, García-Alfonso P, Rodríguez-Gil Y, et al. Expert consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the determination of biomarkers in pancreatic and biliary tract cancer. Clin Transl Oncol. 2022 Nov;24:2107–19.; https://hdl.handle.net/11351/8778Test; 000844495200002

  10. 10
    دورية أكاديمية

    المساهمون: Sartore-Bianchi, Andrea Univ Milan La Statale, Dept Oncol & Hematooncol, Niguarda Canc Ctr, Piazza Osped Maggiore 3, I-20162 Milan, Italy, Garcia-Alfonso, Pilar Gen Univ Gregorio Maranon, Dept Oncol, Madrid, Spain, Geissler, Michael Stadt Klinikum Karlsruhe, Geschaftsfuhrung, Karlsruhe, Germany, Kohne, Claus-Henning Klinikum Oldenburg, Dept Oncol & Haematol, Oldenburg, Germany, Peeters, Marc Antwerp Univ, Dept Oncol, Antwerp Univ Hosp, Edegem, Belgium, Price, Timothy Univ Adelaide, Haematol & Med Oncol Unit, Queen Elizabeth Hosp, Adelaide, SA, Australia, Valladares-Ayerbes, Manuel Hosp Univ Reina Sofia, Dept Med Oncol, CIBERONC, IMIBIC, Cordoba, Spain, Zhang, Ying Amgen Inc, Biostat, Thousand Oaks, CA 91320 USA, Burdon, Peter Amgen Europe GmbH, European Med, Rotkreuz, Switzerland, Taieb, Julien Paris Descartes Univ, Georges Pompidou European Hosp, Sorbonne Paris Cite, Paris, France, Modest, Dominik P. Charite Univ Med Berlin, Med Dept, Div Hematol Oncol & Tumor Immunol, Campus Virchow Klinikum CVK, Berlin, Germany, Valladares-Ayerbes, Manuel Virgen del Rocio Hosp, Med Oncol Unit, Seville, Spain, Burdon, Peter MSD Int GmbH, Zurich, Switzerland, Amgen (Europe), GmbH (Rotkreuz, Switzerland)